Home
Pontifax Management 4 G.P. reported a 7.7% stake in Climb Bio CLYM · 5,206,380 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 7.7%
- Last report
- First report
- Shares held
- 5,206,380 sh
- Class
- Common Stock, par value $0.0001 per share
- Stock
- Climb Bio CLYM
- Event date
- 24/06/27
- Filed
- 25/09/18
First 5%+ report · 7.7% stake
Climb Bio trades, last 26 weeks
What else happened in Climb Bio around then
Filed or reported within 30 days of the trade day · 24/05/28~24/07/27Pontifax Management 4 G.P.'s other 5% stake reports
- Pontifax Management 4 G.P.
5% stakeAgomAb Therapeutics
5% stakeAgomAb Therapeutics
AGMB
6.8% stake
3,305,846 sh
6.8% stake
Filed 04/16
- Pontifax Management 4 G.P.
5% stakeKeros Therapeutics
5% stakeKeros Therapeutics
KROS
0% stake
0 sh
0% stake
Filed 25/10/16
- Pontifax Management 4 G.P.
5% stakeLB Pharmaceuticals
5% stakeLB Pharmaceuticals
LBRX
6.3% stake
1,411,681 sh
6.3% stake
Filed 25/09/25
- Pontifax Management 4 G.P.
5% stakeKeros Therapeutics
5% stakeKeros Therapeutics
KROS
11.8% stake
4,787,331 sh
11.8% stake
Filed 25/04/18
